21 CFR 640.50
§ 640.50 Cryoprecipitated AHF.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 640.50, § 640.50 Cryoprecipitated AHF, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/88491
- Permanent ID
ys:prov:88491@1- SHA-256
3de8cbd15e6cca2b0dfca40dd0e4158cb76f50add524877cf4ec839860b7f444
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Proper name and definition. The proper name of this product shall be Cryoprecipitated AHF. The product is defined as a preparation of antihemophilic factor, which is obtained from a single unit of plasma collected and processed in a closed system.
(b) Source. The source material for Cryoprecipitated AHF shall be plasma which may be obtained by whole blood collection or by plasmapheresis.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.